Pharmaceutical Technology6d
FDA approves Alvotech and Teva’s SELARSDI for new indications
The FDA has approved a new presentation of Alvotech and Teva’s SELARSDI, for the treatment of ulcerative colitis and Crohn's ...
Yahoo Finance6d
FDA approves Alvotech and Teva’s SELARSDI for new indications
The US Food and Drug Administration (FDA) has approved a new presentation of Alvotech and Teva Pharmaceuticals’ SELARSDI (ustekinumab-aekn), expanding its label to include the treatment of ...
Monthly Prescribing Reference7d
New Presentation, Indications Approved for Biosimilar Selarsdi
The Food and Drug Administration (FDA) has approved a new presentation of Selarsdi ™ (ustekinumab-aekn), a biosimilar to ...
The Pharma Letter7d
FDA approves new presentation of biosimilar drug Selarsdi
Iceland-based Alvotech and the US unit of Israel’s of Teva Pharmaceutical Industries today revealed that that the US Food and ...
Drug Store News12h
Alvotech, Teva obtain FDA nod for new Selarsdi indication
The FDA approval of Selarsdi 130 mg/26 ml in a single-dose vial for intravenous infusion expands the label to include ...
Alvotech and Teva Secure FDA Approval for SELARSDI
Alvotech (ALVO) has released an update. Alvotech and Teva Pharmaceuticals have received U.S. FDA approval for a new intravenous presentation of ...
Alvotech And Teva Pharmaceuticals Announce Expansion Of SELARSDI's Indications
Alvotech (ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced the FDA has ...
Investing7d
FDA approves SELARSDI for Crohn’s and ulcerative colitis
REYKJAVIK, Iceland & PARSIPPANY, N.J. – The U.S. Food and Drug Administration (FDA) has expanded the approved use of SELARSDI (ustekinumab-aekn) to include the treatment of adults with Crohn's ...
Investing7d
FDA approves SELARSDI for Crohn’s and ulcerative colitis
REYKJAVIK, Iceland & PARSIPPANY, N.J. – The U.S. Food and Drug Administration (FDA) has expanded the approved use of SELARSDI (ustekinumab-aekn) to include the treatment of adults with Crohn's disease ...
Nasdaq7d
Alvotech and Teva Secure FDA Approval for SELARSDI
Alvotech (ALVO) has released an update. Alvotech and Teva Pharmaceuticals have received U.S. FDA approval for a new intravenous presentation of SELARSDI, enhancing its use for Crohn’s disease ...